A Case of Erythema Dyschromicum Perstans
Abstract
Erythema dyschromicum perstans (EDP) is an acquired disease
presenting as ashy dermatosis comprising blue–grey pigmented patches
over the neck, trunk, and extremities. The pigmentation may become
disfiguring when present for a long time. The aetiology of EDP is unclear,
and there is no defined treatment or established therapy. EDP has a
presentation mimicking lichen planus pigmentosus, idiopathic eruptive
macular pigmentation, post-inflammatory hyperpigmentation, fixed
pigmented erythema, Addison’s disease, and hemochromatosis. All
these pigmentation disorders make the diagnosis and treatment of
EDP quite challenging. No treatment for EDP has been universal, and
combination treatments have worked in different cases to cure this
disease.
How to cite this article:
Katariya K, Singhal P, Lamia. A Case of Erythema
Dyschromicum Perstans. Rec Adv Path Lab Med.
2023;9(3&4): 11-13.
DOI: https://doi.org/10.24321/2454.8642.202306
References
Chang SE, Kim HW, Sin JM, Lee JH, Na JI, Roh MR. Clinical
and histological aspect of erythema dyschromicum
perstans in Korea: a review of 68 cases. J Dermatol.
Nov;42(11):1053-7. [PubMed] [Google Scholar]
Ramirez CO. Los cenicientos: problema clinico.
Proceedings of the First Central American Congress
of Dermatology; 1957 Dec 5–8. San Salvador; 1957.
[Google Scholar]
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Recent Advances in Pathology and Laboratory Medicine ( ISSN: 2454-8642 )
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.